Female Urinary Incontinence: Diagnosis and Treatment

Abstract

Female urinary incontinence is a pathology with significant implications for patients and their families and has a great economic impact on health services. In the United Kingdom, it is estimated that 46% of women who access primary care clinics complain of stress urinary incontinence, urgency or mixed (box): for each of these variants there are care pathways based on the predominant symptom. This article summarizes the most recent recommendations of the National Institute for Health and Care Excellence (NICE) on assisting women with urinary incontinence and replaces the previous guideline published in October 2006, the updating of which was necessary due to the availability of new treatments (eg botulinum toxin type A, urethral sling) and continuous technological innovations. The NICE recommendations are based on a systematic review of the best available evidence and on explicit consideration of the cost-effectiveness of health interventions. When the evidence is limited, the recommendations are based on the experience of the group that produced the guideline - Guidelines Development Group (GDG) - and on the rules of good clinical practice.
Copyright © 2019 Praise Worthy Prize - All rights reserved.